Difference between revisions of "MR Coordinating Committee"
Jump to navigation
Jump to search
Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
− | :Chairs: Michael Boss, PhD | + | :Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Caroline Chung, MD; Cathy Elsinger, PhD |
:RSNA Staff Support: Susan Stanfa | :RSNA Staff Support: Susan Stanfa | ||
[https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true Roster] | [https://docs.google.com/spreadsheets/d/e/2PACX-1vReaE9KRKRnlwhq95r9wrvLzVcZMg5iehJatSFB4ZtrDgP99-Fg-kT1Mqiqhxj6IkUDgFqF-jItmXEO/pubhtml?gid=1050413002&single=true Roster] |
Revision as of 18:51, 26 January 2021
- Co-Chairs: Michael Boss, PhD; Thomas L. Chenevert, PhD; Caroline Chung, MD; Cathy Elsinger, PhD
- RSNA Staff Support: Susan Stanfa
Scope
The MR Coordinating Committee coordinates Biomarker Committees based on MR.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the MR Biomarker Committees
Meetings
- Tcons are held Quarterly. Contact RSNA Staff for details.